Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 71335-2966

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 71335-2966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352966)

This text is a pharmaceutical package insert for capsules containing Chlordiazepoxide Hydrochloride and Clidinium Bromide. The usual adult dosage is one or two capsules 3 or 4 times a day, before meals and at bedtime. The medication guide should be dispensed to each patient by the pharmacist, and it should be kept out of reach of children. The capsules should be stored at 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication is manufactured by Sunrise Pharmaceutical, Inc. and dispensed by Bryant Ranch Prepack, Inc. in Burbank, CA, USA.*

FDA Label Image

Image Description (Structure Chlordiazepoxide)

FDA Label Image

Image Description (Structure Clidinium)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.